Skip to content

Evaluating Biobanking Educational Tools

Evaluating Biobanking Educational Tools

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01672944
Enrollment
339
Registered
2012-08-27
Start date
2010-09-27
Completion date
2021-09-17
Last updated
2021-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm

Keywords

Biological specimen banks, Health education, Tissue banks, Health care survey, Tissue

Brief summary

The purpose of this study is to evaluate English and Spanish language educational materials that inform the community about a type of cancer research that involves the collection, storage, and processing of biospecimens. Part A of this study involved creating surveys about biospecimen donation and research. Now, a randomized controlled trial (RCT) will begin to evaluate education materials about biospecimen donation and research. Phase II consists of two independent randomized controlled trials. Each trial is being conducted independently to test English and Spanish language materials (75 subjects each).

Detailed description

The project addresses gaps in information by developing and validating English and Spanish language instruments to measure knowledge of and attitudes towards biospecimen donation and banking, as well as intention to donate biospecimens to a biobank (Part A). Once developed, the instruments will be used to evaluate biobanking educational priming tools by conducting two independent RCTs. Wherein English educational materials will be tested with 75 participants recruited from an urban clinic, and Spanish educational materials will be tested with 75 participant recruited form a rural community health center network. For each RCT following baseline assessment, participants will be randomized to either: 1) educational priming tools (DVD and booklet) developed by the Tampa Bay Community Cancer Network (TBCCN); or 2) an NCI-developed brochure entitled Providing Your Tissue for Research: What You Need to Know. Seven to 28 days later participants will be given a telephone follow up interview.

Interventions

OTHERTBCCN-developed educational materials

Participants will be asked to view the educational materials developed by TBCCN, in either English or Spanish depending on the RCT in which they are enrolled. These materials include a DVD and a booklet that were developed to enhance community members' understanding and awareness of biospecimen collection and biobanking from healthy individuals.

OTHERNCI-developed educational materials

Participants will be asked to view the English biobanking educational Brochure entitled Providing your Tissue for Research: What you need to Know, or Spanish brochure entitled Lo que usted debe saber antes de dar sus tejidos para investigación médica.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

English Language RCT Inclusion Criteria: * scheduled for an appointment at Lifetime Cancer Screening (LCS) * able to read and speak English * able to provide informed consent Spanish Language RCT Inclusion Criteria: * receiving care at a participating clinic from the Suncoast Community Health Centers network * able to read and speak Spanish * able to provide informed consent

Exclusion criteria

* previously diagnosed with cancer * previously participated in a biobank * participated in another TBCCN-related study entitled community perceptions on biobanking

Design outcomes

Primary

MeasureTime frameDescription
BANKS-Knowledge ScaleAverage of 28 daysAdministered at baseline and between 7 and 28 days after enrollment. Description: A validated 16-item questionnaire measuring knowledge about biobanking.
BANKS-Attitudes ScaleAverage of 28 daysAdministered at baseline and between 7 and 28 days after enrollment. Description: A validated 15-item questionnaire measuring attitudes toward biobanking.
BANKS-Self-Efficacy ScaleAverage of 28 daysAdministered at baseline and between 7 and 28 days after enrollment. Description: A validated 12-item questionnaire measuring self-efficacy in regards to donating a biospecimen to a biobank.
BANKS-IntentionsAverage of 28 daysAdministered at baseline. Description: A single item measuring intentions to donate a biospecimen to a biobank.
Decisional Self-EfficacyAverage of 28 daysAdministered at follow-up (between 7 and 28 days after enrollment). Description: A validated 11-item questionnaire measuring participant's confidence in making a decision about donating a biospecimen (O'Connor M.A. Decision Self-efficacy Scale. 1995; www.ohri.ca/decisionaid).

Secondary

MeasureTime frameDescription
BANKS-Trust ScaleAverage of 28 daysAdministered at baseline and between 7 and 28 days after enrollment. Description: A validated 10-item questionnaire measuring trust related to organizations, facilities, and people that may be involved in research.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026